• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ对原代人肝细胞药物转运体 mRNA 表达的调控。

Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes.

机构信息

EA 4427 Signalisation et Réponse aux Agents Infectieux et Chimiques, Institut de Recherches en Santé Environnement Travail, Université de Rennes 1, Rennes, France.

出版信息

Fundam Clin Pharmacol. 2011 Feb;25(1):99-103. doi: 10.1111/j.1472-8206.2010.00822.x.

DOI:10.1111/j.1472-8206.2010.00822.x
PMID:20199580
Abstract

Interferon (IFN)-γ is known to downregulate expression of drug detoxifying proteins such as cytochromes P-450 (CYPs) in human hepatocytes. The present study was designed to determine whether IFN-γ may also impair expression of influx and efflux drug transporters, which constitute important determinants of the liver detoxification pathway. Exposure of primary human hepatocytes to 10 ng/mL IFN-γ was found to downregulate mRNA levels of sinusoidal influx transporters such as sodium-taurocholate cotransporting polypeptide, organic anion transporting polypeptide (OATP) 2B1, OATP1B1, and OATP1B3. IFN-γ concomitantly reduced mRNA expression of drug efflux pumps such as multidrug resistance gene 1, multidrug resistance protein (MRP) 2, MRP3, breast cancer resistance protein and bile salt export pump. Such IFN-γ-mediated repression of major hepatic drug transporters may contribute to impaired liver clearance of drugs administrated to patients suffering from inflammation or viral infections associated with increased secretion of IFN-γ.

摘要

干扰素 (IFN)-γ 已知可下调人肝细胞中药物解毒蛋白(如细胞色素 P-450(CYPs))的表达。本研究旨在确定 IFN-γ 是否也会损害流入和流出药物转运体的表达,这些转运体构成肝脏解毒途径的重要决定因素。研究发现,将原代人肝细胞暴露于 10ng/mL IFN-γ 可下调胆汁酸共转运多肽、有机阴离子转运多肽 (OATP) 2B1、OATP1B1 和 OATP1B3 等窦状隙流入转运体的 mRNA 水平。IFN-γ 同时降低了多药耐药基因 1、多药耐药蛋白 (MRP) 2、MRP3、乳腺癌耐药蛋白和胆盐输出泵等药物外排泵的 mRNA 表达。IFN-γ 介导的主要肝药物转运体的这种抑制作用可能导致与 IFN-γ 分泌增加相关的炎症或病毒感染患者所给予的药物肝脏清除率受损。

相似文献

1
Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes.干扰素-γ对原代人肝细胞药物转运体 mRNA 表达的调控。
Fundam Clin Pharmacol. 2011 Feb;25(1):99-103. doi: 10.1111/j.1472-8206.2010.00822.x.
2
Regulation of drug transporter expression by oncostatin M in human hepatocytes.奥曲肽 M 对人肝细胞药物转运体表达的调控。
Biochem Pharmacol. 2011 Aug 1;82(3):304-11. doi: 10.1016/j.bcp.2011.04.017. Epub 2011 May 6.
3
Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.肝细胞生长因子对原代人肝细胞药物转运体表达的差异调节。
Drug Metab Dispos. 2009 Nov;37(11):2228-35. doi: 10.1124/dmd.109.028035. Epub 2009 Aug 6.
4
Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.暴露于促炎细胞因子白细胞介素1β的人肝细胞中有机阴离子转运体表达的下调。
Drug Metab Dispos. 2008 Feb;36(2):217-22. doi: 10.1124/dmd.107.016907. Epub 2007 Nov 8.
5
Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.促炎细胞因子肿瘤坏死因子-α或白细胞介素-6作用下人类肝细胞中药物转运体表达的调控
Drug Metab Dispos. 2009 Mar;37(3):685-93. doi: 10.1124/dmd.108.023630. Epub 2008 Dec 15.
6
Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes.人原代肝细胞和大鼠原代肝细胞中窦状隙药物转运体的功能表达
Drug Metab Dispos. 2005 Oct;33(10):1418-22. doi: 10.1124/dmd.105.004762. Epub 2005 Jul 13.
7
Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.分化人肝癌 HepaRG 细胞中药物转运蛋白的极化表达。
Toxicol In Vitro. 2013 Sep;27(6):1979-86. doi: 10.1016/j.tiv.2013.07.003. Epub 2013 Jul 12.
8
Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.柴油机尾气颗粒提取物对人肝药物转运体活性和表达的调节作用
PLoS One. 2015 Mar 24;10(3):e0121232. doi: 10.1371/journal.pone.0121232. eCollection 2015.
9
Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.促炎细胞因子对人肝药物转运体表达的调控。
Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1469-81. doi: 10.1517/17425250903304056.
10
Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes.全反式视黄酸对肝癌 HepaRG 细胞和人肝细胞中药物转运体表达的差异调节。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):767-74. doi: 10.1016/j.ejps.2013.01.005. Epub 2013 Jan 23.

引用本文的文献

1
Roles of organic anion transporting polypeptides in hepatocellular carcinoma.有机阴离子转运多肽在肝细胞癌中的作用。
Front Genet. 2025 Jul 15;16:1550723. doi: 10.3389/fgene.2025.1550723. eCollection 2025.
2
Drug transporter mRNA expression and genital inflammation in South African women on oral pre-exposure prophylaxis (PrEP).南非接受口服暴露前预防(PrEP)的女性中药物转运蛋白mRNA表达与生殖器炎症
AIDS Res Ther. 2025 Feb 15;22(1):18. doi: 10.1186/s12981-025-00713-z.
3
Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.
用于HIV长效暴露前预防的抗逆转录病毒药物转运体的药物基因组学
Front Genet. 2022 Sep 29;13:940661. doi: 10.3389/fgene.2022.940661. eCollection 2022.
4
expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.在高级别浆液性卵巢癌中,表达与激活的炎症信号通路相关。
Front Pharmacol. 2022 Aug 29;13:946348. doi: 10.3389/fphar.2022.946348. eCollection 2022.
5
Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition.炎症诱导P-糖蛋白、乳腺癌耐药蛋白和多药耐药相关蛋白2功能表达的变化:不同模型概述及其对药物处置的影响
Pharmaceutics. 2021 Sep 23;13(10):1544. doi: 10.3390/pharmaceutics13101544.
6
Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.2019冠状病毒病中的疾病-药物及药物-药物相互作用:风险与评估
Biomed Pharmacother. 2021 Jul;139:111642. doi: 10.1016/j.biopha.2021.111642. Epub 2021 Apr 27.
7
Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.创新方法和药物代谢和转运发生研究的最新进展。
Br J Clin Pharmacol. 2022 Oct;88(10):4285-4296. doi: 10.1111/bcp.14534. Epub 2020 Sep 15.
8
The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions.人类有机阴离子转运多肽(OATPs)在药物与草药/食物相互作用中的作用。
Chin Med. 2020 Jul 9;15:71. doi: 10.1186/s13020-020-00351-9. eCollection 2020.
9
Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.有机阴离子转运多肽和有机阴离子转运体的转运及其他调节机制,这些机制调节细胞对药物和外源性物质的摄取,且在疾病中失调。
Br J Pharmacol. 2017 Jul;174(13):1908-1924. doi: 10.1111/bph.13785. Epub 2017 Apr 24.
10
Bicarbonate transport inhibitor SITS modulates pH homeostasis triggering apoptosis of Dalton's lymphoma: implication of novel molecular mechanisms.碳酸氢盐转运抑制剂SITS调节pH稳态并引发道尔顿淋巴瘤细胞凋亡:新分子机制的意义
Mol Cell Biochem. 2014 Dec;397(1-2):167-78. doi: 10.1007/s11010-014-2184-2. Epub 2014 Aug 15.